Certolizumab-induced optic neuritis in a patient with spondyloarthritis: A case report and review of the literature

Therapie. 2023 Nov 29:S0040-5957(23)00189-0. doi: 10.1016/j.therap.2023.11.006. Online ahead of print.

Authors

Hiba Boussaa¹, Saffet Nouicer², Saoussen Miladi¹, Yasmine Makhlouf¹, Kawther Ben Abdelghani¹, Alia Fazaa¹, Ahmed Laatar¹

Affiliations

¹ Department of Rheumatology, Mongi Slim Hospital, 2046 Sidi Daoued, La Marsa, Tunisia; University Tunis El Manar of Medicine, Faculty of Medicine of Tunis, 1007 Tunis, Tunisia.
² Department of Rheumatology, Mongi Slim Hospital, 2046 Sidi Daoued, La Marsa, Tunisia; University Tunis El Manar of Medicine, Faculty of Medicine of Tunis, 1007 Tunis, Tunisia. Electronic address: saffetnouicer0109@gmail.com.

PMID: 38158272
DOI: 10.1016/j.therap.2023.11.006

No abstract available

Keywords: Adverse drug reaction; Certolizumab pegol; Optic neuritis; Spondyloarthritis.

Publication types

Letter